Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
RIGL:NASDAQ
Rigel Pharmaceuticals Inc
$30.56
+0.16%
(+0.050) 1D
$30.56
0.00% (0.00)
After hours
Closed: Apr 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RIGL...
Open
$30.69
High
$31.35
Low
$30.47
Mkt. cap
564.75M
Avg. vol.
339.84K
Volume
13.00
P/E ratio
1.57
52-wk high
$52.24
52-wk low
$16.88
EPS
$19.48
Beta
1.27
Shares outstanding
18.48M
No. of employees
173
News stories
From sources across the web
About Rigel Pharmaceuticals Inc
CEO-
Employees173
Founded1996
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiterigel.com
Last report
Mar 3, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
1.12/ (1.20 est.)USD
-6.80%miss
Revenue / Estimate
69.80M/ (68.70M est.)USD
+1.60%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
53.33M
101.68M
69.46M
69.80M
Cost of goods sold
12.84M
11.32M
12.11M
16.64M
Cost of revenue
12.84M
11.32M
12.11M
16.64M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.72M
29.26M
28.94M
29.99M
Operating expense
27.72M
29.26M
28.94M
29.99M
Total operating expenses
40.56M
40.58M
41.04M
46.63M
Operating income
12.77M
61.10M
28.42M
23.17M
Other non operating income
-
-
-
-
EBT including unusual items
11.51M
59.98M
27.62M
22.71M
EBT excluding unusual items
11.51M
59.98M
27.62M
22.71M
Income tax expense
65.00K
369.00K
-280.00K
-245.35M
Effective tax rate
0.56%
0.62%
-1.01%
-1,080.18%
Other operating expenses
-
-
-
-
Net income
11.45M
59.61M
27.90M
268.06M
Net profit margin
21.46%
58.63%
40.17%
384.04%
Earnings per share
0.63
3.28
1.46
1.12
Interest and investment income
591.00K
753.00K
1.09M
1.24M
Interest expense
-1.85M
-1.87M
-1.89M
-1.70M
Net interest expenses
-1.26M
-1.12M
-800.00K
-456.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
13.38M
61.71M
29.02M
23.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more